Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

In vivo particle-mediated cytokine gene transfer into canine oral mucosa and epidermis.

Keller ET, Burkholder JK, Shi F, Pugh TD, McCabe D, Malter JS, MacEwen EG, Yang NS, Ershler WB.

Cancer Gene Ther. 1996 May-Jun;3(3):186-91.

PMID:
8725883
2.

CWR22 xenograft as an ex vivo human tumor model for prostate cancer gene therapy.

Cheng L, Sun J, Pretlow TG, Culp J, Yang NS.

J Natl Cancer Inst. 1996 May 1;88(9):607-11.

PMID:
8609662
3.
4.

Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs.

Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Yang NS, MacEwen EG.

Cancer Gene Ther. 1999 Jan-Feb;6(1):26-36.

5.

Systemic genetic transfer of p21WAF-1 and GM-CSF utilizing of a novel oligopeptide-based EGF receptor targeting polyplex.

Liu X, Tian PK, Ju DW, Zhang MH, Yao M, Cao XT, Gu JR.

Cancer Gene Ther. 2003 Jul;10(7):529-39.

PMID:
12833133
6.

Gene gun-mediated oral mucosal transfer of interleukin 12 cDNA coupled with an irradiated melanoma vaccine in a hamster model: successful treatment of oral melanoma and distant skin lesion.

Wang J, Murakami T, Hakamata Y, Ajiki T, Jinbu Y, Akasaka Y, Ohtsuki M, Nakagawa H, Kobayashi E.

Cancer Gene Ther. 2001 Oct;8(10):705-12.

7.

In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG, Pugh TD, Ershler WB, Yang NS.

Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2889-93.

8.

Gene gun application in the generation of effector T cells for adoptive immunotherapy.

Tanigawa K, Yu H, Sun R, Nickoloff BJ, Chang AE.

Cancer Immunol Immunother. 2000 Feb;48(11):635-43.

9.

Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors.

Weber SM, Shi F, Heise C, Warner T, Mahvi DM.

Ann Surg Oncol. 1999 Mar;6(2):186-94.

PMID:
10082045
10.

Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.

Gordon EM, Levy JP, Reed RA, Petchpud WN, Liu L, Wendler CB, Hall FL.

Int J Oncol. 2008 Oct;33(4):665-75.

PMID:
18813779
11.

Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer.

Kim SH, Carew JF, Kooby DA, Shields J, Entwisle C, Patel S, Shah JP, Fong Y.

Cancer Gene Ther. 2000 Sep;7(9):1279-85.

12.
13.

DNA cancer vaccines: a gene gun approach.

Mahvi DM, Sheehy MJ, Yang NS.

Immunol Cell Biol. 1997 Oct;75(5):456-60. Review.

14.

Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells.

Okada H, Villa L, Attanucci J, Erff M, Fellows WK, Lotze MT, Pollack IF, Chambers WH.

Gene Ther. 2001 Aug;8(15):1157-66.

16.

Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes.

Ali SA, McLean CS, Boursnell ME, Martin G, Holmes CL, Reeder S, Entwisle C, Blakeley DM, Shields JG, Todryk S, Vile R, Robins RA, Rees RC.

Cancer Res. 2000 Mar 15;60(6):1663-70.

17.

Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.

Stagg J, Wu JH, Bouganim N, Galipeau J.

Cancer Res. 2004 Dec 15;64(24):8795-9.

18.

Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.

Chi CH, Wang YS, Lai YS, Chi KH.

Anticancer Res. 2003 Jan-Feb;23(1A):315-21.

PMID:
12680230
19.

Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.

Majumdar AS, Zolotorev A, Samuel S, Tran K, Vertin B, Hall-Meier M, Antoni BA, Adeline E, Philip M, Philip R.

Cancer Gene Ther. 2000 Jul;7(7):1086-99.

20.

Efficient retrovirus-mediated cytokine-gene transduction of primary-cultured human glioma cells for tumor vaccination therapy.

Wakimoto H, Yoshida Y, Aoyagi M, Hirakawa K, Hamada H.

Jpn J Cancer Res. 1997 Mar;88(3):296-305.

PMID:
9140115

Supplemental Content

Support Center